Fibrinogen Replacement: A Questionable Dogma
Hämostaseologie · 01.08.2025 · 45 (04) · 320-323
DOI: 10.1055/a-2535-8910 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hämostaseologie, erschienen am 01.08.2025. Verfasst von Patricia Duque und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Gregorio Marañon Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Fibrinogen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Management of hemostasis in the perioperative setting, in trauma or in acute care, has considerably changed over the last two decades. Viscoelastic testing and single-factor replacement therapies have become cornerstones of the respective clinical approaches. Here, we illuminate the basic theories for these approaches as well as the important evidence available. Both viscoelastic assays and single-factor replacements are important improvements; their use must be based on the strongest scientific evidence available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, Gregorio Marañon Hospital, Madrid, Spain.
- Haemostasis and Haemophilia Center, St. Gallen, Switzerland.
Zitieren
APA
Duque, P., & Korte, W. (2025). Fibrinogen Replacement: A Questionable Dogma. Hämostaseologie, 45(04), 320-323. https://doi.org/10.1055/a-2535-8910
Vancouver
Duque P, Korte W. Fibrinogen Replacement: A Questionable Dogma. Hämostaseologie. 2025;45(04):320-323. doi:10.1055/a-2535-8910
BibTeX
@article{Duque2025,
author = {Duque, Patricia and Korte, Wolfgang},
title = {Fibrinogen Replacement: A Questionable Dogma},
journal = {Hämostaseologie},
year = {2025},
volume = {45},
number = {04},
pages = {320--323},
doi = {10.1055/a-2535-8910}
}
EUVIMED